Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW642444M dose-ranging placebo-controlled study in persistent asthma
2007-001713-42Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vilanterol in persistent asthma and asthma (6 arms), sponsored by GSK. Primary endpoint: Mean change from baseline in clinic visit trough pre-bronchodilator and pre-dose lung function. Started Dec 2007; status: completed.
02
Drugs
vilanterol
03
Conditions
persistent asthmaasthma
Beyond the preview
Go deeper on 2007-001713-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001713-42.